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Background/aim: To investigate the effects of keratinocyte growth factor (KGF) on the growth and transdifferentiation of primary
alveolar epithelial type II cells (AECIIs).
Materials and methods: The number of primary AECIIs, their viability, and cell cycle and apoptosis were studied under KGF treatment
using a hemocytometer, trypan blue exclusion, and flow cytometry, respectively. Positive expressions of surfactant protein C (SP-C),
aquaporin 5 (AQP5), and thyroid transcription factor 1(TTF-1) were examined with indirect immunofluorescence; mRNA levels of SPC, AQP5, and TTF-1 were determined by polymerase chain reaction.
Results: In response to KGF treatment, cell numbers were significantly increased, more cells were blocked in the S phase, and fewer
cells were apoptotic or necrotic on days 2 and 4, but there was little effect on cell viability. In addition, KGF treatment resulted in higher
levels of SP-C on days 2 and 8 while lowering them on day 4, higher levels of AQP5 on day 4 while lowering them on day 8, and higher
levels of TTF-1 on days 2, 6, and 8.
Conclusion: KGF treatment promoted proliferation of AECIIs, inhibited cell apoptosis, promoted transdifferentiation of AECIIs, and
induced alveolar epithelial type I cells to revert to AECIIs.
Key words: Keratinocyte growth factor, alveolar epithelial type II cells, transdifferentiation, surfactant protein C, aquaporin 5, thyroid
transcription factor-1

1. Introduction
Keratinocyte growth factor (KGF) is a paracrine mitogenic
agent produced by stromal cells (1). It mediates the
interaction between mesenchymal and epithelial cells. It
is crucially important in normal lung development and
acts as a protective agent after many different types of
lung injury. KGF enhances alveolar epithelial tightness
by altering the actin cytoskeleton to protect the lung
from acute injury (2). It also can activate transepithelial
ion transport in alveoli and preserves expression of water
channels to alleviate high-altitude pulmonary edema
(3). An increasing number of studies suggest that KGF
protects the lungs from a variety of damage via different
mechanisms (4), as well as regulating the development
of bronchi during maturation of the fetal lung (5).
Nevertheless, the underlying protective mechanism of
KGF remains elusive.
* Correspondence: niculzg@163.com

It is well established that alveolar epithelial type II cells
(AECIIs) serve to defend the alveoli, and their functions
include synthesis and secretion of pulmonary surfactant,
activation of ion transport, and maintenance and repair
of alveolar epithelium after lung injury (6). Primary
AECIIs cultured over a period of 3 to 4 days gradually
transdifferentiate to alveolar epithelial type I cells (AECIs).
Studies have shown that KGF promotes the proliferation,
differentiation, and maturation of AECIIs through a KGF
paracrine loop (7) and efficiently prevents the damage of
intracellular injured DNA (3). However, the physiological
links among KGF, AECIIs, and pulmonary development
need to be further investigated. In consideration of the
multiple effects of KGF on lung development and the
healing of injuries, the present study investigated the
effects of KGF on AECII proliferation and differentiation,
which may reveal the physiological roles of KGF in the
prevention of pulmonary damage.
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2. Materials and methods
2.1. Rat preparation
Adult Sprague Dawley rats were obtained from the Beijing
Academy of Military Medical Sciences Animal Research
Center. The Animal Ethics Committee of Binzhou Medical
University Affiliated Hospital approved the animal
experiments. The study was performed from January to
July in 2012.
Female rats (230–260 g) and male rats (300–350 g) were
housed in the same cages at a female-to-male ratio of 2:1.
Vaginal smears from the females were examined at 0800
hours for the presence of sperm, which indicated positive
mating. The morning on which evidence of mating was
found was considered day zero (D0) of pregnancy.
2.2. AECII isolation and culture
On day 19 of gestation the pregnant rats were anesthetized
and pups were removed by cesarean section. The AECIIs
were isolated from fetal rats as previously described (8).
The AECIIs were randomly divided into a control
group and a KGF group. The KGF group cells were cultured
in a cell-culture medium at a final KGF concentration of
10 ng/mL. The control group was cultured in an identical
cell culture medium but without KGF. The cells of both
groups were maintained in an incubator with a humidified
atmosphere and 5% CO2. Each of the 2 groups was further
divided into 2-, 4-, 6-, and 8-day subgroups according to
the culture incubation period.
2.3. Assessment of cell number
The filtered and purified AECIIs were suspended and
adjusted to a cell confluency of approximately 4 × 105/mL.
Cell suspension (0.5 mL) was plated into individual wells
of 24-well plates. The cells in 5 wells were harvested and
contents were digested with 0.25% trypsin every 48 h, and
the cell number was counted with a hemocytometer under
an inverted microscope. The mean number of cells in the
5 wells was considered the cell number for each sample.
2.4. Assay of cell viability
Cell viability was determined via trypan blue exclusion at
each time point. Briefly, 9 drops of cell suspension were
mixed with 1 drop of 0.4% trypan blue. Living and dead
cells were counted with a blood counting plate within 3
min. The percentage of the total number of cells that were
living was calculated. Each sample was counted 5 times
and the mean was calculated from these.
2.5. Assay of cell cycle
At each culture time point, 1 × 105 cells were harvested and
washed twice with cold phosphate buffered saline (PBS).
Cells were resuspended with 250 µL of trypsin buffer and
kept at room temperature for 10 min, then mixed with 200
µL of buffer B (trypsin inhibitor and RNase buffer) and
kept at room temperature for another 10 min. Propidium
iodide (PI) dye (200 µL) was added and cells were kept at
2–8 °C for 10 min. The cell suspension was finally filtered
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through a 200-mesh sieve and the distribution of cell cycle
phases was examined with a FACScan flow cytometer (BD
Biosciences, USA) using a Cycletest Plus DNA staining kit
in accordance with the manufacturer’s instructions (BD
Biosciences, 340242). The percentage of cells in each phase
of the cell cycle was calculated.
2.6. Analysis of apoptosis
Rates of apoptosis were analyzed by flow cytometry.
An annexin V-fluorescein isothiocyanate (FITC) kit
(CX1001) was used in accordance with the manufacturer’s
instructions (Beijing Biosea Biotechnology, China). Results
were analyzed using CellQuest and Motifit software.
Stained cells were separated into 3 subgroups: 1) viable
cells with intact cell membranes without externalized
phosphatidylserine (lower left quadrant, annexin V-/
PI-); 2) early apoptotic cells with intact cell membranes
and with externalized phosphatidylserine (lower right
quadrant, annexin V+/PI-); 3) late apoptotic cells and
necrotic cells with lost membrane integrity and with
externalized phosphatidylserine (upper right quadrant,
annexin V+/PI+).
2.7. Immunofluorescence
The fluorescence expressions of surfactant protein C (SPC), aquaporin 5 (AQP5), and thyroid transcription factor
1 (TTF-1) were observed with confocal laser scanning
microscopy (C1-SHS, Nikon, Japan) at each time point.
AECIIs were kept in special laser confocal dishes. Cells in
these dishes were fixed with 4% paraformaldehyde for 10
min and washed 3 times with PBS. The primary antibodies
sheep anti-SP-C, rabbit anti-AQP5, and sheep anti TTF1 (Santa Cruz Biotechnology, USA) were added in serial
procedures and the dishes were kept in a wet box at 4 °C for
24 h and washed 3 times with PBS. Antisheep IgG marked
by FITC or antisheep IgG marked by Texas Red (Sigma,
USA) was added and cells were kept in the incubator
at 37 °C for 2 h, followed by washing 3 times with PBS.
One milliliter of 10 ng/mL Hoechst 33342 (Sigma, USA)
was added and the cells in the dishes were kept at room
temperature for 20 min. After washing with PBS, cells were
mounted in Vectashield mounting medium. Finally, cells
were observed with a C1-SHS laser confocal microscope
(Nikon, Japan).
2.8. Detection of mRNA expression of SP-C and AQP5
SP-C and AQP5 mRNAs were detected via reverse
transcription (RT)-PCR (ABI 9700, Applied Biosystems,
USA). The amplified PCR products were resolved in
agarose and visualized at ultraviolet wavelength 260 nm.
The amount of SP-C or AQP5 was calculated relative to
glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
2.9. Detection of mRNA expression of TTF-1
The expression of TTF-1 was examined via quantitative
fluorescent PCR, performed in accordance with the
manufacturer’s instructions (RG6000, Corbett).
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Relative changes in gene expression were determined
using the relative quantitative (2–ΔΔCt) method, where F =
2–ΔΔCt, and Ct is the threshold cycle (i.e. the cycle number
at which fluorescence reached the set threshold). ΔCt was
calculated by subtracting the Ct value of the GAPDH
reference from the Ct values of the gene expression of
interest (that is, the sample): ΔCtsample = Ctsample – CtGAPDH.
ΔΔCt was calculated by subtracting the ΔCt of the control
from the ΔCt of the sample: ΔΔCt = ΔCtsample – ΔCtcontrol.
The 2–ΔΔCt value (F) represents the relative fold changes
in expressed quantity between the control and the target
gene (9).
2.10. Statistical analysis
All data were presented as mean ± standard deviation
(SD) and analysis was performed using SPSS 11.5. The
interaction effect of incubation time and culture group
was analyzed by factorial analysis of variance (ANOVA).
Differences between groups were analyzed using Student’s
t-test while differences among multiple groups were
analyzed by one-way ANOVA. The Bonferroni method
was used to correct for multiple comparisons. P < 0.05 was
considered statistically significant.

3. Results
3.1. KGF treatment significantly facilitated AECII
proliferation
With the isolated AECIIs, we initially investigated the
effects of KGF on cell growth (Figure 1). The cells in
the KGF group showed regular morphology with clear
nucleoli. The cells in the KGF group grew more quickly
and had more dikaryocytes on days 2 and 4. The number
of cells in the KGF group was significantly higher than that
of the control group on days 2, 4, 6, and 8 (P < 0.05; Table
1). In total, these results indicated that the KGF treatment
facilitated AECII proliferation.
3.2. KGF treatment did not affect cell viability
We then examined the effect of KGF on cell viability.
Compared with cells in the control group, KGF treatment
did not significantly change the viability of AECIIs at any
measured time point (Table 2). Altogether, these results
indicated that the KGF treatment had very little effect on
cell viability.
3.3. KGF treatment caused alteration of the cell cycle in
AECIIs
To examine the effect of KGF on the AECII cell cycle, we
analyzed the cell phase distribution after KGF treatment.

A

B

C

D

Figure 1. The number of AECIIs in the KGF group. The number of AECII cells increased on days
2 and 4, and then decreased in a time-dependent fashion (200×). A) Day 2. The number of cells was
greater on day 2 than at day 0. The cells attached to the dish tightly, and there were some dikaryocytes.
B) Day 4. The cell number was significantly increased at the culture time point of day 4 in the KGF group.
C) Day 6. The number of cells gradually decreased on day 6. D) Day 8. The number of cells gradually
decreased on day 8.
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Table 1. Comparison of cell population size (×105/mL) between the control and KGF groupsa (mean ± SD).
Time (days)

Control group

KGF group

0

4.02 ± 0.99

4.00 ± 0.09

2

10.41 ± 0.24

4

t/F

P

0.391

0.701

b

14.104

0.000

28.13 ± 1.93 b

37.49 ± 1.50 b

11.505

0.000

6

27.12 ± 0.85

36.19 ± 0.86

22.159

0.000

8

26.29 ± 1.59

35.23 ± 1.22

13.374

0.000

F

748.852

1879.459

P

0.000

0.000

57.065 c

0.000 c

b

16.00 ± 0.93

n = 5.
P < 0.05 compared with preceding culture time point.
c
Interaction effect.
a

b

Table 2. Comparison of cell viability between control and KGF groupsa (mean ± SD%).
Time (days)

Control group

KGF group

t/F

P

2

97.00 ± 0.71

97.60 ± 1.14

1.000

0.347

4

97.20 ± 0.84

97.60 ± 1.14

0.632

0.545

6

95.00 ± 0.71 b

95.60 ± 0.89 b

1.177

0.273

8

92.80 ± 1.30 b

93.20 ± 0.84 b

0.577

0.580

F

24.863

21.333

P

0.000

0.000

0.036 c

0.991 c

n = 5.
P < 0.05 compared with preceding culture time point.
c
Interaction effect.
a

b

Compared with cells in the control group, those in the
KGF group were markedly more concentrated in the S
phase but less concentrated in the G1 phase (Table 3;
Figure 2), suggesting that KGF treatment arrested cells in
the S phase.
3.4. KGF treatment inhibited AECII apoptosis
To analyze the effect of KGF on AECII apoptosis, we
determined the percentage of apoptotic cells after KGF
treatment. On days 2 and 4, compared with the control
group, the percentage of early apoptotic/necrotic cells in
the KGF group was significantly less (P < 0.05), while the
difference was not significant on days 6 and 8 (P > 0.05).
On day 2, compared with the control group, the percentage
of late apoptotic cells and necrotic cells of the KGF group
was significantly less (P < 0.05), but the difference was not
significant on days 4, 6, and 8 (P > 0.05; Table 4; Figure
3). Altogether, these results indicated that KGF treatment
inhibited apoptosis of AECIIs.
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3.5. Effect of KGF on the expression of SP-C, AQP5, and
TTF-1 and their mRNA levels
SP-C is the only identified active protein that is expressed
in AECIIs, and SP-C expression can be used to identify
AECIIs (10). AQP5 is localized in the apical membrane
of AECIs, and AQP5 expression can be used to identify
AECIs (6). TTF-1 is a transcription factor characteristic
of AECIIs (11).
The fluorescent intensity of SP-C (green fluorescence),
AQP5 (red fluorescence), and TTF-1 are consistent with
the expressions of SP-C mRNA, AQP5 mRNA, and TTF-1
mRNA (Figure 4).
Shown by this simple effect analysis, the expression of
SP-C mRNA in the KGF group was greater than that of the
control group on days 2 and 8 (P = 0.008 and P = 0.000,
respectively) and was less than that of the control group on
day 4 (P = 0.000), while the difference was not significant at
day 6 (P = 0.709; Table 5). The expressions of AQP5 mRNA
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Table 3. Comparison of the percent of cells in G1 and S between the control and KGF groupsa (mean ± SD%).
Time (days)
2
4
6
8
F
P

Cycle phase

Control group

KGF group

t/F

P

G1

64.03 ± 1.24

60.43 ± 1.60

3.973

0.004

S

22.15 ± 0.85

31.14 ± 1.23

13.457

0.000

G1

64.82 ± 1.29

50.90 ± 1.34 b

16.696

0.000

S

23.02 ± 1.09

37.91 ± 1.15 b

21.021

0.000

G1

64.40 ± 1.85

54.11 ± 1.24

b

10.324

0.000

S

22.20 ± 1.27

34.01 ± 1.22 b

15.020

0.000

G1

65.68 ± 1.09

56.79 ± 1.28

b

11.789

0.000

S

22.01 ± 1.07

30.92 ± 1.25

b

12.082

0.000

G1

1.282

43.221

23.830 c

S

0.891

36.114

15.250

G1

0.314

0.000

–

0.000 c

S

0.467

0.000

–

0.000 c

c

–
–

n = 5.
P < 0.05 compared with preceding culture time point.
c
Interaction effect.
a

b

Figure 2. Cell cycle in the KGF group. The proportion of cells in G1 phase cells declined sharply on
day 4, then rose gradually on days 6 and 8. The proportion of cells in the S phase was highest on day
4. A) Day 2. B) Day 4. C) Day 6. D) Day 8.
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Table 4. Comparison of the percentage of apoptotic cells between the control group and KGF groupa (mean ± SD%).
Time (days)

Control group

KGF group

t/F

P

Annexin V /PI

7.78 ± 0.57

6.78 ± 0.52

2.900

0.020

Annexin V /PI

7.88 ± 0.71

3.55 ± 0.64

10.104

0.000

Annexin V+/PI–

14.11 ± 1.06 b

12.15 ± 1.44 b

2.442

0.040

Annexin V+/PI+

6.93 ± 1.10

6.77 ± 0.64 b

0.278

0.788

Annexin V /PI

11.86 ± 0.83

b

12.06 ± 0.99

0.339

0.743

+

Annexin V /PI

12.16 ± 1.61

b

11.46 ± 0.47

0.937

0.376

Annexin V+/PI–

11.85 ± 0.85

11.47 ± 1.20

0.569

0.585

Annexin V+/PI+

12.29 ± 0.68

11.39 ± 0.71

2.061

Annexin V /PI

48.723

27.737

2.225

Annexin V /PI

33.038

192.347

11.400

Annexin V+/PI–

0.000

0.000

–

0.104 c

Annexin V+/PI+

0.000

0.000

–

0.000 c

+

2
4

+

+

6
8

+

+

F
P

+

–
+

–

–
+

b

0.073
–

c
c

–

n = 5.
P < 0.05 compared with preceding culture time point.
c
Interaction effect.

a

b

Figure 3. Apoptosis in the KGF group. The proportion of annexin V+/PI- and annexin V+/PI+
cells declined obviously on day 2. The proportion of annexin V +/ PI- cells was highest on day 4,
and the proportion of annexin V +/PI+ cells was highest on day 8. A) Day 2. B) Day 4. C) Day 6.
D) Day 8.
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a

b

c

d

e

f

Figure 4. Fluorescence expression of AQP5, SP-C, and TTF-1 (200×). A) Red punctiform expression of AQP5 on
surface of AECIIs. B) Green fluorescence showing SP-C in cytoplasm of AECIIs. C) Expression of SP-C in cytoplasm
and AQP5 on the surface. D) Expression of TTF-1 in nucleus after 2 days of culture; control group. E) Expression of
TTF-1 in nucleus after 4 days of culture; control group. F) The expression of TTF-1 in nucleus of AECIIs after 2 days of
culture; KGF group.
Table 5. Comparison of mRNA expressions of SP-C and AQP5 between the control group and KGF groupa (mean ±
SD A260 value).
Time (days)
2
4
6
8
F
P

mRNA

Control group

KGF group

t/F

P

SP-C

0.74 ± 0.07

0.94 ± 0.10

3.483

0.008

AQP5

0.20 ± 0.04

2.169

0.062

0.25 ± 0.04

SP-C

1.22 ± 0.12

12.034

0.000

AQP5

0.33 ± 0.05 b

0.71 ± 0.07 b

9.558

0.000

SP-C

0.70 ± 0.08

b

0.71 ± 0.07

b

0.387

0.709

AQP5

0.55 ± 0.09

b

0.52 ± 0.05

b

0.669

0.522

b

0.86 ± 0.06

b

15.193

0.000

b

0.53 ± 0.05

b

SP-C

0.30 ± 0.06

AQP5

0.68 ± 0.08 b

0.33 ± 0.05 b

8.299

SP-C

102.804

29.298

110.086

AQP5

49.751

76.522

60.745

SP-C

0.000

0.000

–

0.000 c

AQP5

0.000

0.000

–

0.000 c

0.000
c

c

–
–

n = 5.
P < 0.05 compared with preceding culture time point.
c
Interaction effect.
a

b
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A

B
SP-C mRNA
GAPDH

M

8 days

6 days

4 days

AQP5mRNA
GAPDH

2 days

M

C

8 days

6 days

4 days

2 days

D
AQP5mRNA

SP-C mRNA
GAPDH

M

8 days

6 days

4 days

GAPDH

2 days

M

8 days

6 days

4 days

2 days

Figure 5. RT-PCR of SP-C mRNA and AQP5 mRNA. A) RT-PCR of SP-C mRNA in control group. B) RT-PCR of
AQP5 mRNA in control group. C) RT-PCR of SP-C mRNA in KGF group. D) RT-PCR of AQP5 mRNA in KGF
group.

was greater than that of the control group on day 4 (P =
0.000) and was less than that of the control group on day
8 (P = 0.000), while the difference was not significant on
days 2 and 6 (P = 0.062 and P = 0.522; Table 5). The mRNA
level of TTF-1 was greater than that of the control group
on days 2, 6, and 8 (P < 0.05, all), while the difference was
not significant on day 4 (P > 0.05; Table 6). These results
suggest that KGF treatment promoted transdifferentiation
of AECIIs, and made the AECI cell-like phenotype revert
to that of AECII.
4. Discussion
KGF is a member of the fibroblast growth factor family,
which was originally isolated and purified from cultured
human embryonic lung fibroblasts, and is expressed
in various organs including the lungs (12). KGF is the

only member in its family that is expressed in epithelial
cells but not in fibroblasts and endothelial cells. It has
been documented that KGF promoted rapid repair of
transplanted lung trachea and increased the number
of cycled progenitor epithelial cells in the airway (13).
Although KGF is not the only effective mitogen, it is an
effective inducer of the differentiation of AECIIs (14).
Nevertheless, the protective mechanism is not clear.
In this study, we found that the expression of SP-C
in AECIIs after KGF treatment was significantly higher
compared with the untreated control group. This may be
related to a KGF-induced increase of the surfactant content
in epithelial cells. Sadovski et al. (15) found that, compared
with donor lung tissue treated with KGF, the eluates of
transplanted lungs without KGF treatment contained
less protein but comparable phospholipids, while SP-C

Table 6. Comparison of TTF-1 expression between the control group and KGF groupa (mean ± SD × E-04).
Time (days)

Control group

KGF group

t/F

P

2

11.83 ± 1.05

14.53 ± 0.91

4.347

0.002

4

14.23 ± 1.20

2.255

0.054

10.097

0.000

22.470

0.000

64.688 c

0.000 c

b

12.67 ± 0.98

6

7.85 ± 1.22

b

15.39 ± 1.14

8

5.54 ± 0.70 b

15.46 ± 0.70

F

67.572

9.440

P

0.000

0.001

n = 5.
P < 0.05 compared with preceding culture time point.
c
Interaction effect.
a

b
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in the lung tissue treated with KGF increased, as well as
pulmonary surfactant. Our observations are consistent
with these results, suggesting that higher SP-C levels
induced by KGF treatment may be an intrinsic protective
mechanism in pulmonary injury.
Earlier studies showed that AECIIs are the progenitors
of alveolar epithelial cells (16). After lung injury and AECI
damage, AECIIs can proliferate and repair the epithelium.
The proliferation of AECIIs is the normal reaction to
alveolar injury, which can be observed in acute lung injury
and interstitial lung disease. KGF is an effective AECII
mitogen both in vivo and in vitro (17). KGF could induce
the hyperplasia of AECIIs. In the present study we showed
that KGF treatment can facilitate AECII proliferation,
implying that KGF treatment has a central role in AECII
proliferation-mediated protection of lung injury.
KGF promotion of cell proliferation may be via the
influencing of cell-phase transition. It is well known
that cell-cycle arrest occurs at one of two well-defined
checkpoints: the G1/S transition or the G2/M transition.
The cell cycle is the final pathway for cell proliferation, and
it is regulated at various checkpoints, of which the G1–S
phase represents the most important step (18). At this
checkpoint, extra- and intracellular signals are integrated
and transmitted to cells, and they determine whether
cells begin cell division, become apoptotic, or enter the
quiescent G0 phase. In our study, when treated with KGF,
most cells entered the cell division phase and consequently
the cells began to proliferate. We found that KGF treatment
arrested cells in the S phase. A similar phenomenon was
found in other cells by Lin et al. (19). In that study, KGF
could promote oral squamous carcinoma cell proliferation
by increasing the viability of carcinoma cells and inducing
more of them to enter the G2 and S phases (19). However,
regarding cell viability, we did not find in the present study
any significant difference between the KGF treatment
group and the control group. However, the mechanism
underlying the effect of KGF on the cell cycle is not well
elucidated. One possible mechanism is that stimulation
with KGF may upregulate the expression of cyclin D1 and
downregulate p21, and thus induce cells to pass the G1–S
phase checkpoint (20) and begin automatic division.
Moreover, some studies have shown that KGF could
inhibit the apoptosis of intestinal epithelial cells (21,22).
The inhibition of the apoptosis of AECIIs was also observed

in our present research. However, the mechanism involved
in this process is still not clear.
Previous studies have shown that AQP5 is a marker
of AECI, and SP-C is a marker of AECII (6,10). In the
present study, our evaluation showed that KGF promoted
transdifferentiation of AECIIs, as well as making AECIs
revert to AECIIs. This suggests that the promotion effect
of KGF was bidirectional. However, little is known about
the signal transduction pathways that regulate phenotypic
transitions between AECIIs and AECIs. Qiao et al. (6)
found that c-Jun activation is a crucial pathway through
which KGF mediates phenotypic transitions in AECs. It
is likely that KGF made AECIs retrotransdifferentiate to
AECIIs via this mechanism and then mediated protective
effects after injury and during repair of the lung.
The TTF-1 gene is essential to lung development (23).
To date, the investigation of KGF effects on the expression of
TTF-1 are limited. In this study we found that the expression
of TTF-1 mRNA in KGF-treated AECIIs was significantly
greater compared with the control group. Tichelaar et
al. (24) demonstrated that KGF not only induced the
proliferation of AECIIs, but also increased the expression
of TTF-1. They also showed that the expression of TTF-1
increased at first and then activated the promoter Ccsp.
The research found that there were two consistent TTF-1
sites between the 197 and 158 DNA in SP-C. Mutagenesis
in one of the two sites could completely block the activation
of TTF-1. This showed that the two sites were essential
in the transcription activation of TTF-1 to SP-C. As KGF
promoted the proliferation of AECII and the expression of
SP-C, and TTF-1 promoted the expression of SP-C, it seems
that KGF activated the expression of TTF-1 at first and then
TTF-1 stimulated the expression of SP-C, which indicated
that it promoted the proliferation of AECIIs.
In conclusion, according to our cytological study,
KGF administration significantly affected the growth and
transdifferentiation of AECIIs. The proliferation effect of
KGF on AECIIs acted through the promotion of cells into
the S phase, but not by affecting cell viability. In addition,
KGF treatment resulted in fewer apoptotic and necrotic
cells and changed the expression patterns of the genes SPC, AQP5, and TTF-1. However, the association between
KGF and TTF-1 and the mechanism underlying the
inhibition of apoptosis and promotion of differentiation
by KGF will need to be studied further.
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